Table 3.
Demographic and hematological parameters between low-grade gliomas and high-grade gliomas.
| LGGs | HGGs | P | |
|---|---|---|---|
| n | 39 | 34 | |
| Age (year) | 34.72 ± 16.66 | 45.79 ± 14.78 | 0.004* |
| Sex (M/F) | 26/13 | 20/14 | 0.489 |
| Tumor size (cm3) | 76.95 (1.20–270.0) | 98.00 (18.02–439.28) | 0.075 |
| Ki-67 (%) | 5.0 (1.0–15.0) | 35.0 (10.0–80.0) | <0.001* |
| sPD-L1 (ng/mL) | 0.4623 ± 0.2166 | 0.6316 ± 0.2899 | 0.006* |
| Hematological markers | |||
| WBC (109/L) | 6.34 ± 1.57 | 7.09 ± 1.9 | 0.070 |
| Neutrophils (109/L) | 3.76 ± 1.2 | 4.81 ± 1.58 | 0.002* |
| Lymphocytes (109/L) | 2.09 ± 0.87 | 1.73 ± 0.6 | 0.046* |
| Monocytes (109/L) | 0.35 ± 0.11 | 0.42 ± 0.15 | 0.015* |
| Platelets (109/L) | 233.44 ± 63.17 | 252.88 ± 60.4 | 0.185 |
| Albumin (g/L) | 45.95 ± 3.12 | 44.62 ± 2.82 | 0.062 |
| NLR | 2.00 ± 0.79 | 3.09 ± 1.37 | <0.001* |
| dNLR | 1.24 ± 0.08 | 1.33 ± 0.12 | <0.001* |
| PLR | 122.39 ± 46.45 | 164.34 ± 72.37 | 0.005* |
| PNI | 56.39 ± 5.48 | 53.26 ± 3.89 | 0.007* |
| AGR | 1.77 ± 0.24 | 1.63 ± 0.24 | 0.012* |
An asterisk (*) indicates a significant difference.
NLR, neutrophil-to-lymphocyte ratio; dNLR, derived NLR; PLR, platelet-to-lymphocyte ratio; PNI, prognostic nutritional index; AGR, albumin-to-globulin ratio.